BENEFIT Act of 2021
Latest action · Jul 19, 2021 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedJul 16, 2021
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2021 or the BENEFIT Act of 2021
This bill requires the Food and Drug Administration (FDA) to consider relevant patient-focused drug development data, such as data from patient preference studies and patient-reported outcome data, in the risk-benefit assessment framework used in the process for approving new drugs.
After a new drug application has been approved, the FDA's public statement about how it used patient experience data shall include a description of how such data was considered in the risk-benefit assessment framework.
Cosponsors 17
Members who signed on, in the order they did. Signatures ran from Jul 16, 2021 to May 27, 2022; 1 is an original cosponsor, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-OH | Brad R. Wenstrup | Original | Jul 16, 2021 |
| R-PA | Brian K. Fitzpatrick | Jul 21, 2021 | |
| R-CA | Doug LaMalfa | Aug 13, 2021 | |
| D-CA | Tony Cárdenas | Nov 4, 2021 | |
| R-NE | Don Bacon | Jan 20, 2022 | |
| D-GA | Sanford D. Bishop, Jr. | Mar 2, 2022 | |
| D-PA | Susan Wild | Mar 8, 2022 | |
| D-FL | Darren Soto | Mar 9, 2022 | |
| D-NY | Brian Higgins | Mar 11, 2022 | |
| R-NE | Jeff Fortenberry | Mar 11, 2022 | |
| D-DC | Eleanor Holmes Norton | Mar 15, 2022 | |
| D-MO | Emanuel Cleaver | Mar 15, 2022 | |
| R-OK | Tom Cole | Mar 16, 2022 | |
| R-SC | Ralph Norman | Mar 17, 2022 | |
| R-PR | Jenniffer González-Colón | Apr 18, 2022 | |
| R-CA | Young Kim | Apr 27, 2022 | |
| D-CA | Mark DeSaulnier | May 27, 2022 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Jul 16, 2021 |
| Health Subcommittee | Referred Jul 19, 2021 |
Actions 3
Everything that happened, newest first.
- Jul 19, 2021Referred to the Subcommittee on Health.
- Jul 16, 2021Introduced in House
- Jul 16, 2021Referred to the House Committee on Energy and Commerce.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 167, no. 125, July 16, 2021, page H3633.
Printed hearings 1
Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.
| Number | Hearing | Committee | Held |
|---|---|---|---|
| Serial No. 117-75 | THE FUTURE OF MEDICINE: LEGISLATION TO ENCOURAGE INNOVATION AND IMPROVE OVERSIGHT308 pages | Energy and Commerce Committee | Mar 17, 2022 |
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 373 | BENEFIT Act of 2021 | Identical bill | Feb 23, 2021 |
Titles 3
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To strengthen the use of patient-experience data within the benefit-risk framework for approval of new drugs.
- Short Title(s) as Introduced
- BENEFIT Act of 2021
- Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2021
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Jul 16, 2021Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
